CAMBRIDGE, England, May 27, 2024--Dato-DXd TL01 OS HLR
AstraZeneca (AZN) announces an ambitious target of achieving $80 billion in revenues by 2030. Pfizer (PFE) announces a multi-year, multi-phase cost reduction program.
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...